The KRAS oncogene: Past, present, and future

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1756, Issue 2, 2005, Pages 81-82

  Kranenburg, Onno ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE;

AMINO ACID SUBSTITUTION; CELL TRANSFORMATION; COLORECTAL CANCER; EDITORIAL; GENE ACTIVATION; GENE ISOLATION; GENE TARGETING; HUMAN; NONHUMAN; ONCOGENE K RAS; PANCREAS CANCER; POINT MUTATION; PRIORITY JOURNAL; PROTEIN STRUCTURE;

GENES, RAS; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; ONCOGENES; PROTO-ONCOGENE PROTEINS P21(RAS); TUMOR CELLS, CULTURED;

EID: 28844481452     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbcan.2005.10.001     Document Type: Editorial

References (23)

1. C.J. Der, T.G. Krontiris, and G.M. Cooper Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses Proc. Natl. Acad. Sci. U. S. A. 79 1982 3637 3640
2. J. Downward Targeting RAS signalling pathways in cancer therapy Nat. Rev., Cancer 3 2003 11 22
3. M. Malumbres, and M. Barbacid RAS oncogenes: the first Nat. Rev., Cancer 3 2003 459 465
4. C.F. Kim, E.L. Jackson, A.E. Woolfenden, S. Lawrence, I. Babar, and S. Vogel Identification of bronchioalveolar stem cells in normal lung and lung cancer Cell 121 2005 823 835
5. K.P. Janssen, F. El Marjou, D. Pinto, X. Sastre, D. Rouillard, and C. Fouquet Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice Gastroenterology 123 2002 492 504
6. K.P. Janssen, M. Abala, F. El Marjou, D. Louvard, and S. Robine Mouse models of K-ras-initiated carcinogenesis Biochim. Biophys. Acta, Rev. Cancer 2005 (this issue)
7. A.J. Aguirre, N. Bardeesy, M. Sinha, L. Lopez, D.A. Tuveson, and J. Horner Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma Genes Dev. 17 2003 3112 3126
8. P.M. Pour, K.K. Pandey, and S.K. Batra What is the origin of pancreatic adenocarcinoma? Mol. Cancer 2 2003 13
9. J.L. Bos ras oncogenes in human cancer: a review Cancer Res. 49 1989 4682 4689
10. H.J. Andreyev, A.R. Norman, D. Cunningham, J.R. Oates, and P.A. Clarke Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study J. Natl. Cancer Inst. 90 1998 675 684
11. H.J. Andreyev, A.R. Norman, D. Cunningham, J. Oates, B.R. Dix, and B.J. Iacopetta Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study Br. J. Cancer 85 2001 692 696
12. W.S. Samowitz, K. Curtin, D. Schaffer, M. Robertson, M. Leppert, and M.L. Slattery Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study Cancer Epidemiol. Biomarkers Prev. 9 2000 1193 1197
13. W. Luo, and M. Sharif Stable expression of activated Ki-Ras does not constitutively activate the mitogen-activated protein kinase pathway but attenuates epidermal growth factor receptor activation in human astrocytoma cells Int. J. Oncol. 14 1999 53 62
14. D.A. Tuveson, A.T. Shaw, N.A. Willis, D.P. Silver, E.L. Jackson, and S. Chang Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects Cancer Cell 5 2004 375 387
15. M.T. Yip-Schneider, A. Lin, D. Barnard, C.J. Sweeney, and M.S. Marshall Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression Int. J. Oncol. 15 1999 271 279
16. B. Friday, and A. Adjei KRAS as a target for cancer therapy Biochim. Biophys. Acta, Rev. Cancer 2005 (this issue)
17. L. Johnson, D. Greenbaum, K. Cichowski, K. Mercer, E. Murphy, and E. Schmitt K-ras is an essential gene in the mouse with partial functional overlap with N-ras Genes Dev. 11 1997 2468 2481
18. K. Koera, K. Nakamura, K. Nakao, J. Miyoshi, K. Toyoshima, and T. Hatta K-ras is essential for the development of the mouse embryo Oncogene 15 1997 1151 1159
19. Z. Zhang, Y. Wang, H.G. Vikis, L. Johnson, G. Liu, and J. Li Wildtype Kras2 can inhibit lung carcinogenesis in mice Nat. Genet. 29 2001 25 33
20. P. Castagnola, and W. Giaretti Mutant KRAS, chromosomal instability and prognosis in colorectal cancer Biochim. Biophys. Acta, Rev. Cancer 2005 (this issue)
21. T. Deramaudt, and A. Rustgi Mutant KRAS in the initiation of pancreatic cancer Biochim. Biophys. Acta, Rev. Cancer 2005 (this issue)
22. T.P. Pretlow, and T.G. Pretlow Mutant KRAS in aberrant crypt foci (ACF): initiation of colorectal cancer? Biochim. Biophys. Acta, Rev. Cancer 2005 (this issue)
23. N. Smakman, R.I. Borel, E.E. Voest, and O. Kranenburg Control of colorectal metastasis formation by K-Ras Biochim. Biophys. Acta, Rev. Cancer 2005 (this issue)